Results 191 to 200 of about 99,190 (260)

Impact of Metformin and Diabetes on Tumor Response to Total Neoadjuvant Therapy in Advanced Rectal Cancer: A Multicenter Retrospective Cohort Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
In advanced rectal cancer patients receiving total neoadjuvant therapy (TNT), overall tumor response did not differ by diabetes status or metformin use. However, among diabetic patients, metformin use was associated with higher overall complete response rates. These findings suggest a potential benefit of metformin in enhancing TNT response in diabetic
Sergei Bedrikovetski, Mahima Raju, Tracy Fitzsimmons, Ishraq Murshed, Timothy J. Price, Michael Penniment, Sudarsha Selva‐Nayagam, Tarik Sammour   +7 more
wiley   +1 more source

Pharmacological and Phytochemical Insights Into <i>Ficus benghalensis</i> (Indian Banyan): Anti-Inflammatory, Antioxidant, and Anticancer Potentials. [PDF]

Food Sci Nutr
Ali Z, Awlqadr FH, Ali U, Ullah I, Arshad MT, Rauf A, Parveen H, Mukhtar S, Faridi U, Hossain MS.   +9 more
europepmc   +1 more source

Diabetes‐Induced Testicular Injury: Potential Protective Roles of Curcumin, Garcinia kola, and Momordica charantia in Rats

Andrology, EarlyView.
ABSTRACT Background Diabetes mellitus (DM) induces multifaceted cellular and structural alterations in the male reproductive system, thereby predisposing to infertility. Objectives This study aimed to evaluate the morphological, stereological, biochemical, histopathological, and ultrastructural changes induced by DM in testicular tissue, and to ...
Ayşenur Kaya Mutlu, Süleyman Kaplan
wiley   +1 more source

Repurposing Antidiabetic Medications for Parkinson's Disease: Focus on Biomarker Strategies for Disease Modification. [PDF]

Int J Mol Sci
Yelleswarapu NK, Sidiropoulos C.
europepmc   +1 more source

Prospective Short‐ and Long‐Term Changes in Cardiometabolic Risk Markers Following Gender‐Affirming Hormone Therapy

Andrology, EarlyView.
ABSTRACT Introduction Gender‐affirming hormone therapy (GAHT) may be associated with increased cardiometabolic disease (CMD) risk. Prospective CMD risk screening is recommended, but long‐term data are needed regarding changes in CMD markers. Objectives To evaluate prospective changes in CMD risk markers during GAHT.
Louise Lehmann Christensen, Camilla Viola Palm, Marianne S. Andersen, Guy T'Sjoen, Jan Frystyk, Tine Taulbjerg Kristensen, Rikke Hjortebjerg, Dorte Glintborg   +7 more
wiley   +1 more source

Inhibition of Diabetes-Related Enzymes by Plant Secondary Metabolites: A Promising Therapeutic Strategy. [PDF]

Life (Basel)
Șeremet OC, Andrei C, Pușcașu C, Zanfirescu A, Nițulescu G, Gîrd CE, Olaru OT.   +6 more
europepmc   +1 more source

Outcomes of a Novel Surgery: Gastrojejunal-Ileal Interposition with Bipartition and Sleeve Gastrectomy for Type 2 Diabetes and Obesity. [PDF]

J Clin Med
Demirel T, Sut N, Ugale S.
europepmc   +1 more source

Peptidomic profiling and molecular dynamics study of bioactive peptides from fermented camel milk: considering the fermentation time dependent proteolysis by <i>Lactobacillus</i> and <i>Saccharomyces</i> with antidiabetic, antioxidative and anti-inflammatory activities. [PDF]

Front Nutr
Padhiyar PN, Mankad PM, Ramanuj K, Sakure AA, Bhattacharya A, Kondepudi KK, Tiwary BK, Liu Z, Patel A, Hati S.   +9 more
europepmc   +1 more source

Mogrosides as Dual-Function Sweeteners: A Comprehensive Review of Extraction, Metabolism, Antidiabetic Mechanisms, and Food Applications. [PDF]

Nutrients
Feng Q, Wang T, Wang Q, Pan H, Zhong Y, Zhuang Y.   +5 more
europepmc   +1 more source

Polyphenols of <i>Zingiber roseum</i> Leaf as a Potential Source of α‑Glucosidase Inhibitors for Type‑2 Diabetes Management: LC-MS/MS, Pharmacological and Computational Analysis. [PDF]

ACS Omega
Sakib MS, Eruygur N, Ahmed S, Yilmaz MA, Mannan Siam SM, Moniruzzaman M, Naim Uddin SM, Tarhan A, Rahman MN, Shahid Ud Daula AFM.   +9 more
europepmc   +1 more source